SCHEMBL16623565

SCHEMBL16623565

N=C(c1ccc(N2CCCC2=O)cc1)c1c(Nc2c(F)cccc2F)cc[nH]c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
RAB9A P51151 6/20 0.40
NPC1 O15118 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
TP53 P04637 2/20 0.40
GLA P06280 1/20 0.40
PKM P14618 1/20 0.40
GFER P55789 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 5/20 0.38
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C9 P11712 2/20 0.37
MAPT P10636 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623493 0.86 TYK2 (0.39)
SCHEMBL17849221 0.85 EIF2AK2 (0.34) RAB9ANPC1
SCHEMBL17849238 0.84 L3MBTL1 (0.38) RAB9AKMT2A
SCHEMBL18052623 0.84 EGFR (0.36)
SCHEMBL16623503 0.83 EGFR (0.35)
SCHEMBL17849193 0.83 F10 (0.43) ALDH1A1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL17849188 0.82 EGFR (0.40) ALDH1A1RAB9ANPC1MAPT
SCHEMBL17849249 0.82 EGFR (0.40) ALDH1A1TSHR
SCHEMBL16623558 0.79 PARP1 (0.34)
SCHEMBL16623511 0.78 TYK2 (0.38) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
EP-2857400-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed